600267 海正药业
已收盘 05-20 15:00:00
资讯
新帖
简况
海正药业05月20日遭主力抛售644万元 环比增加101.25%
自选股智能写手 · 15:17
海正药业05月20日遭主力抛售644万元 环比增加101.25%
海正药业最新公告:控股子公司阿莫西林克拉维酸钾干混悬剂获得新兽药注册证书
证券之星 · 05-17 17:51
海正药业最新公告:控股子公司阿莫西林克拉维酸钾干混悬剂获得新兽药注册证书
海正药业(600267.SH)子公司阿莫西林克拉维酸钾干混悬剂获新兽药注册证书
智通财经 · 05-17 17:47
海正药业(600267.SH)子公司阿莫西林克拉维酸钾干混悬剂获新兽药注册证书
海正药业:聘任蒋灵为公司高级副总裁兼财务总监
智通财经 · 05-17 17:34
海正药业:聘任蒋灵为公司高级副总裁兼财务总监
海正药业(600267.SH)子公司获得赛拉菌素滴剂兽药产品批准文号批件
智通财经 · 05-15
海正药业(600267.SH)子公司获得赛拉菌素滴剂兽药产品批准文号批件
海正药业: 公司已经有此安排
证券之星 · 05-10
海正药业: 公司已经有此安排
海正药业(600267.SH):在合成生物学方面,通过基因编辑技术提升核心品种菌种生产水平取得成效
格隆汇资讯 · 05-10
海正药业(600267.SH):在合成生物学方面,通过基因编辑技术提升核心品种菌种生产水平取得成效
海正药业(600267.SH):在减肥药领域现有品种奥利司他
格隆汇资讯 · 05-10
海正药业(600267.SH):在减肥药领域现有品种奥利司他
动物疫苗概念盘中跳水,海正药业跌1.15%
自选股智能写手 · 05-10
动物疫苗概念盘中跳水,海正药业跌1.15%
AI制药新进展:谷歌推出新一代模型 产业链一览
腾讯自选股 · 05-09
AI制药新进展:谷歌推出新一代模型 产业链一览
去年净利润由盈转亏,“老将”回归后,这家台州老牌药企能否重新起航?
华夏时报网 · 05-06
去年净利润由盈转亏,“老将”回归后,这家台州老牌药企能否重新起航?
海正药业获融资买入0.16亿元,近三日累计买入0.40亿元
金融界 · 05-01
海正药业获融资买入0.16亿元,近三日累计买入0.40亿元
海正药业(600267)4月30日主力资金净卖出112.17万元
证券之星 · 05-01
海正药业(600267)4月30日主力资金净卖出112.17万元
海正药业2023年营收103.73亿 董事长沈星虎薪酬47.23万
挖贝网 · 04-30
海正药业2023年营收103.73亿 董事长沈星虎薪酬47.23万
青蒿素概念盘中拉升,海正药业涨3.16%
自选股智能写手 · 04-30
青蒿素概念盘中拉升,海正药业涨3.16%
图解海正药业一季报:第一季度单季净利润同比增6.99%
证券之星 · 04-30
图解海正药业一季报:第一季度单季净利润同比增6.99%
图解海正药业年报:第四季度单季净利润同比减448.94%
证券之星 · 04-30
图解海正药业年报:第四季度单季净利润同比减448.94%
海正药业(600267.SH)发布一季度业绩,净利润2.49亿元,同比增长6.99%
智通财经 · 04-30
海正药业(600267.SH)发布一季度业绩,净利润2.49亿元,同比增长6.99%
加载更多
公司概况
公司名称:
浙江海正药业股份有限公司
所属行业:
医药制造业
上市日期:
2000-07-25
主营业务:
浙江海正药业股份有限公司主营化学原料药和制剂的研发、生产和销售业务,具体包括:化学原料药业务、制剂业务、生物药业务和医药商业业务,公司先后获得“国家高新技术企业”、“全国五一劳动奖状”等荣誉,入选国家首批“创新型企业”、“国家知识产权示范企业”。
发行价格:
11.83
{"stockData":{"symbol":"600267","market":"SH","secType":"STK","nameCN":"海正药业","latestPrice":8.26,"timestamp":1716188400000,"preClose":8.34,"halted":0,"volume":11795450,"delay":0,"floatShares":1192000000,"shares":1208000000,"eps":-0.0637,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.08,"latestTime":"05-20 15:00:00","open":8.26,"high":8.33,"low":8.1,"amount":97115800,"amplitude":0.0276,"askPrice":8.26,"askSize":54,"bidPrice":8.25,"bidSize":1036,"shortable":0,"etf":0,"ttmEps":-0.0637,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716255000000},"adr":0,"adjPreClose":8.34,"symbolType":"stock","openAndCloseTimeList":[[1716168600000,1716175800000],[1716181200000,1716188400000]],"highLimit":9.17,"lowLimit":7.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1207873716,"pbRate":1.25,"roa":"--","roe":"3.1%","epsLYR":-0.08,"committee":0.096927,"marketValue":9977000000,"floatMarketCap":9844000000,"peRate":-129.670334,"changeRate":-0.0096,"turnoverRate":0.0099,"status":1},"requestUrl":"/m/hq/s/600267","defaultTab":"news","newsList":[{"id":"2436234111","title":"海正药业05月20日遭主力抛售644万元 环比增加101.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436234111","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436234111?lang=zh_cn&edition=full","pubTime":"2024-05-20 15:17","pubTimestamp":1716189451,"startTime":"0","endTime":"0","summary":"05月20日, 海正药业股价跌0.96%,报收8.26元,成交金额9711万元,换手率0.99%,振幅2.76%,量比1.18。海正药业今日主力资金净流出644万元,连续7日净流出,上一交易日主力净流出320万元,今日环比增加101.25%。|05月20日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|瑞迪智驱|7.43%|#|新研股份|4.52%|#|晓程科技|4.34%|#|润贝航科|3.55%|#|皇庭国际|3.33%|#|瑜欣电子|2.92%|#|贝肯能源|2.80%|#|凤凰航运|2.51%|#|冠龙节能|2.30%|#|高新发展|2.22%|海正药业所在的化学制药行业,今日主力净流出1.25亿元,行业排名24/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520152118877ce8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520152118877ce8ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436999431","title":"海正药业最新公告:控股子公司阿莫西林克拉维酸钾干混悬剂获得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2436999431","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436999431?lang=zh_cn&edition=full","pubTime":"2024-05-17 17:51","pubTimestamp":1715939482,"startTime":"0","endTime":"0","summary":"海正药业公告,控股子公司海正动保公司收到农业农村部核准签发的阿莫西林克拉维酸钾干混悬剂《新兽药注册证书》,该新兽药产品正式获批五类新兽药。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700034905.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2436999599","title":"海正药业(600267.SH)子公司阿莫西林克拉维酸钾干混悬剂获新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2436999599","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2436999599?lang=zh_cn&edition=full","pubTime":"2024-05-17 17:47","pubTimestamp":1715939251,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业 发布公告,近日,公司控股子公司浙江海正动物保健品有限公司收到中华人民共和国农业农村部核准签发的阿莫西林克拉维酸钾干混悬剂《新兽药注册证书》,该新兽药产品正式获批五类新兽药。阿莫西林克拉维酸钾干混悬剂是海正动保公司自主研制的国内首家获批的五类新兽药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122627.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2436199611","title":"海正药业:聘任蒋灵为公司高级副总裁兼财务总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2436199611","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2436199611?lang=zh_cn&edition=full","pubTime":"2024-05-17 17:34","pubTimestamp":1715938477,"startTime":"0","endTime":"0","summary":"浙江海正药业股份有限公司公告,公司于2024年4月26日召开第九届董事会第二十七次会议,审议通过了《关于聘任公司高级管理人员的议案》,经公司总裁提名,董事会同意聘任蒋灵先生为公司高级副总裁兼财务总监,协助总裁分管相应的工作,任期至本届董事会届满时止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171734408773e841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171734408773e841&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435687414","title":"海正药业(600267.SH)子公司获得赛拉菌素滴剂兽药产品批准文号批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2435687414","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435687414?lang=zh_cn&edition=full","pubTime":"2024-05-15 17:57","pubTimestamp":1715767067,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业(600267.SH)发布公告,近日,公司控股子公司浙江海正动物保健品有限公司(以下简称“海正动保公司”)收到中华人民共和国农业农村部核准签发的赛拉菌素滴剂兽药产品批准文号批件。赛拉菌素滴剂适应症:犬:用于治疗和预防跳蚤(栉首蚤属)感染;预防心丝虫病;治疗虱(啮毛虱)、螨(耳螨、疥螨)和成熟蛔虫(犬弓首蛔虫)感染。猫:用于治疗和预防跳蚤(栉首蚤属)感染;预防心丝虫病;治疗虱(猫羽虱)、螨(耳螨)和成熟蛔虫(猫弓首蛔虫)、成熟肠钩虫(管形钩虫)感染。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121563.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434342088","title":"海正药业:\n公司已经有此安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2434342088","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434342088?lang=zh_cn&edition=full","pubTime":"2024-05-10 19:01","pubTimestamp":1715338914,"startTime":"0","endTime":"0","summary":"证券之星消息,海正药业05月10日在投资者关系平台上答复投资者关心的问题。公司已经有此安排,感谢您的关注!公司已连续三年实施了三次回购公司股份事项,共使用回购资金近5亿元,公司一直高度重视和维护投资者利益。2023年对于海正药业而言,是充满挑战与困难的一年,面对行业的剧变和内部结构的调整,公司全体员工展现出了顽强的拼搏精神。公司在减肥药领域现有品种奥利司他。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000039056.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434833415","title":"海正药业(600267.SH):在合成生物学方面,通过基因编辑技术提升核心品种菌种生产水平取得成效","url":"https://stock-news.laohu8.com/highlight/detail?id=2434833415","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2434833415?lang=zh_cn&edition=full","pubTime":"2024-05-10 17:25","pubTimestamp":1715333126,"startTime":"0","endTime":"0","summary":"格隆汇5月10日丨海正药业(600267.SH)在互动平台表示,公司在合成生物学方面,通过基因编辑技术提升核心品种菌种生产水平取得成效;同时利用酵母类、大肠杆菌、谷氨酸棒杆菌等布局新材料、功能食品及功能护肤品等原料;酶催化技术平台有一个全酶法工艺的原料药获批,同时在进行多个原料药手性中间体工艺开发,重点围绕转氨酶、氧化还原酶、转移酶、连接酶类进行定向筛选。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101725578af080b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101725578af080b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434383341","title":"海正药业(600267.SH):在减肥药领域现有品种奥利司他","url":"https://stock-news.laohu8.com/highlight/detail?id=2434383341","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2434383341?lang=zh_cn&edition=full","pubTime":"2024-05-10 17:24","pubTimestamp":1715333061,"startTime":"0","endTime":"0","summary":"格隆汇5月10日丨海正药业(600267.SH)在互动平台表示,公司在减肥药领域现有品种奥利司他。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101724308af07f3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101724308af07f3e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434008479","title":"动物疫苗概念盘中跳水,海正药业跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434008479","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434008479?lang=zh_cn&edition=full","pubTime":"2024-05-10 11:07","pubTimestamp":1715310427,"startTime":"0","endTime":"0","summary":"05月10日,动物疫苗概念盘中跳水,截至11点07分,动物疫苗概念整体指数下跌0.63%,报794.830点。从个股上来看,该概念的成分股中,海正药业跌1.15%,申联生物、天康生物、大北农跌幅居前。从资金上来看,截止发稿,动物疫苗概念主力净流入为-2.25亿,其中生物股份受到资金热捧,主力净流入1581.01万;拉长时间线来看,该板块近20日主力资金净流入-10.84亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101107077a5923b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101107077a5923b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434611086","title":"AI制药新进展:谷歌推出新一代模型 产业链一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2434611086","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2434611086?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:14","pubTimestamp":1715213647,"startTime":"0","endTime":"0","summary":"美东时间周三,谷歌DeepMind发布了新一代预测蛋白质结构的AlphaFold 3模型,能够帮助科学家更精确地针对疾病机制,从而开发出更有效的治疗药物。据太平洋证券医药,AI制药内涵丰富,主要包括:数字生物学、计算机药物发现、实验室自动化、AI 辅助临床试验等。整体而言AI技术在制药领域的应用价值主要体现在缩短试验周期、节省成本、促进新事物发现、提升试验成功概率等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433844415","title":"去年净利润由盈转亏,“老将”回归后,这家台州老牌药企能否重新起航?","url":"https://stock-news.laohu8.com/highlight/detail?id=2433844415","media":"华夏时报网","top":-1,"share":"https://www.laohu8.com/m/news/2433844415?lang=zh_cn&edition=full","pubTime":"2024-05-06 14:18","pubTimestamp":1714976287,"startTime":"0","endTime":"0","summary":"在此次公告中,海正药业亦表示,目前公司生产经营秩序正常,各项业务稳步推进,日常生产经营活动未受到影响。海正药业公告显示,该保留意见的审计报告不会影响公司触发退市或风险警示,也不会导致公司盈亏性质发生变化。海正药业将持续跟踪相关事项进展并及时履行信息披露义务,切实维护好公司和全体股东的利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050614295487d74f53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050614295487d74f53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432550779","title":"海正药业获融资买入0.16亿元,近三日累计买入0.40亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432550779","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432550779?lang=zh_cn&edition=full","pubTime":"2024-05-01 08:25","pubTimestamp":1714523126,"startTime":"0","endTime":"0","summary":"4月30日,沪深两融数据显示,海正药业获融资买入额0.16亿元,居两市第583位,当日融资偿还额0.18亿元,净卖出288.87万元。最近三个交易日,26日-30日,海正药业分别获融资买入0.06亿元、0.18亿元、0.16亿元。融券方面,当日融券卖出3.19万股,净卖出1.53万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050108265987c5bb22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050108265987c5bb22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432551182","title":"海正药业(600267)4月30日主力资金净卖出112.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432551182","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432551182?lang=zh_cn&edition=full","pubTime":"2024-05-01 07:43","pubTimestamp":1714520616,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月30日收盘,海正药业报收于8.16元,上涨3.29%,换手率2.02%,成交量24.1万手,成交额1.96亿元。近5日资金流向一览见下表:海正药业融资融券信息显示,融资方面,当日融资买入1557.36万元,融资偿还1846.23万元,融资净偿还288.87万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050100012370.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431538492","title":"海正药业2023年营收103.73亿 董事长沈星虎薪酬47.23万","url":"https://stock-news.laohu8.com/highlight/detail?id=2431538492","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2431538492?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:29","pubTimestamp":1714444189,"startTime":"0","endTime":"0","summary":"挖贝网4月30日,海正药业 近日发布2023年年度报告,报告期内公司实现营业收入10,373,071,956.92元,同比下滑13.82%;归属于上市公司股东的净利润-93,171,306.60元,较上年同期由盈转亏。2023年度实现营业收入103.73亿元,同比减少16.64亿元,减少13.82个百分点。公告显示,报告期内董事、监事、高级管理人员报酬合计1,485.28万元。董事长沈星虎从公司获得的税前报酬总额47.23万元,董事会秘书沈锡飞从公司获得的税前报酬总额82.55万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301032268b645451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301032268b645451&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431022978","title":"青蒿素概念盘中拉升,海正药业涨3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431022978","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431022978?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:38","pubTimestamp":1714441096,"startTime":"0","endTime":"0","summary":"04月30日,青蒿素概念盘中拉升,截至09点38分,青蒿素概念整体指数上涨0.65%,报1143.320点。从个股上来看,该概念的成分股中,海正药业涨3.16%,浙江医药、新 和 成、华润双鹤涨幅居前。从资金上来看,截止发稿,青蒿素概念主力净流入为-1066.53万,其中浙江医药受到资金热捧,主力净流入421.83万;拉长时间线来看,该板块近20日主力资金净流入-5.02亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300938167a57862d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300938167a57862d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431810290","title":"图解海正药业一季报:第一季度单季净利润同比增6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431810290","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431810290?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:21","pubTimestamp":1714414880,"startTime":"0","endTime":"0","summary":"证券之星消息,海正药业2024年一季报显示,公司主营收入27.27亿元,同比下降11.0%;归母净利润2.49亿元,同比上升6.99%;扣非净利润1.33亿元,同比下降21.32%;负债率52.44%,投资收益1.23亿元,财务费用3794.71万元,毛利率36.15%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000003228.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431568816","title":"图解海正药业年报:第四季度单季净利润同比减448.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431568816","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431568816?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:50","pubTimestamp":1714409430,"startTime":"0","endTime":"0","summary":"证券之星消息,海正药业2023年年报显示,公司主营收入103.73亿元,同比下降13.82%;归母净利润-9317.13万元,同比下降119.06%;扣非净利润-1.0亿元,同比下降131.98%;其中2023年第四季度,公司单季度主营收入16.72亿元,同比下降49.22%;单季度归母净利润-5.5亿元,同比下降448.94%;单季度扣非净利润-4.32亿元,同比下降950.2%;负债率52.6%,投资收益6605.57万元,财务费用1.92亿元,毛利率40.34%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300059588b62e9f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300059588b62e9f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431890684","title":"海正药业(600267.SH)发布一季度业绩,净利润2.49亿元,同比增长6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431890684","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431890684?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:31","pubTimestamp":1714408267,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海正药业(600267.SH)发布2024年第一季度报告,营业收入27.27亿元,同比减少11%。归属于上市公司股东的净利润2.49亿元,同比增长6.99%。归属于上市公司股东的扣除非经常性损益的净利润1.33亿元,同比减少21.32%。基本每股收益0.21元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115635.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2000-07-25","address":"浙江省台州市椒江区外沙路46号","stockEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":0.1076},{"period":"3month","weight":0.0665},{"period":"6month","weight":-0.1832},{"period":"1year","weight":-0.3113},{"period":"ytd","weight":-0.109}],"companyName":"浙江海正药业股份有限公司","boardCode":"AI0027","perCapita":"19406股","boardName":"医药制造业","registeredCapital":"120787万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":" 浙江海正药业股份有限公司主营化学原料药和制剂的研发、生产和销售业务,具体包括:化学原料药业务、制剂业务、生物药业务和医药商业业务,公司先后获得“国家高新技术企业”、“全国五一劳动奖状”等荣誉,入选国家首批“创新型企业”、“国家知识产权示范企业”。","serverTime":1716194771193,"listedPrice":11.83,"stockholders":"61413人(较上一季度减少2.94%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海正药业,600267,海正药业股票,海正药业股票老虎,海正药业股票老虎国际,海正药业行情,海正药业股票行情,海正药业股价,海正药业股市,海正药业股票价格,海正药业股票交易,海正药业股票购买,海正药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}